Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson’s disease
Objective: To examine plasma iron metabolism related indicators in patients with Parkinson’s disease (PD) and investigate the mechanism underlying the tremor-dominant phenotype of PD. Background:…Regional homogeneity changes detected between Essential tremor with resting tremor and tremor-dominant Parkinson’s disease
Objective: To explore neural activity patterns in the essential tremor (ET) with resting tremor (rET) and tremor-dominant Parkinson's disease (tPD) by using resting-state functional magnetic…Transcranial magnetic stimulation increases cognition globally and longitudinally in Parkinson’s disease
Objective: Using intermittent “theta burst” transcranial magnetic stimulation (iTBS) over the left dorsolateral prefrontal cortex (DLPFC) to assess the potential of long-term improvements in cognitive…Predictive factors of fast cognitive decline in Parkinson’s disease after subthalamic stimulation: Myth or reality?
Objective: To identify pre-operative factors of fast cognitive decline after subthalamic nucleus stimulation (STN DBS) in Parkinson’s disease (PD). Background: Cognitive outcome after STN DBS…The Portuguese Version of Montreal Cognitive Assessment as a screening test comparing Vascular Parkinsonism and Parkinson´s Disease in a hospital cross-section study
Objective: Compare cognitive function between Vascular Parkinsonism (VaP) and Parkinson´s Disease (PD) patients. Background: Portuguese version of Montreal Cognitive Assessment (MoCA) is a validated screening…The comparison of three brief cognitive tests for diagnosing mild cognitive impairment in newly diagnosed Parkinson’s disease
Objective: The aim is to compare the differences of Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA) and Frontal Assessment Battery (FAB) between mild cognitive…Interaction between MAPT H1 and APOE4 in early Parkinson’s Disease
Objective: To define if the high risk MAPT allele of rs393152 (H1 haplotype) is associated with differences in brain structure, clinical presentation, progression or cognitive…Application of the Movement Disorder Society Prodromal Criteria in healthy G2019S-LRRK2 carriers
Objective: To evaluate the MDS prodromal criteria in first-degree relatives of Ashkenazi Jewish G2019S-LRRK2 PD patients, who are considered a population at risk for developing…Early-onset Parkinson’s disease in seven patients with heterozygosity for parkin mutation
Objective: To present and discuss a series of 7 patients with early-onset Parkinson’s Disease and heterozygosity for PARK2 mutation. Background: Parkin mutation in homozygosity or…Molecular-genetic nature of Parkinson’s disease in the East European cohort
Objective: Genetic testing of the Parkin gene in patients with Parkinson's Disease (PD) in the East European cohort from Belarus. Background: The diagnosis of Juvenile…
- « Previous Page
- 1
- …
- 120
- 121
- 122
- 123
- 124
- …
- 177
- Next Page »